flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. ⁣ ⁣ Whether treatment with would mitigate these risks is unknown. ⁣ ⁣ Long-term kidney outcomes of semaglutide

Healthcare providers typically initiate treatment with the lowest possible dose, adjusting as necessary, while carefully observing any changes in kidney function or overall health

In the trial STEP 1, people who took semaglutide lost an average of 15% to 17% of their body weight over 68 weeks, compared to 2.4% for those who took a placebo

At Green Relief Health, the team supports patients through every phase of semaglutide treatment, from starting safely to maintaining results long after stopping

Before starting psyllium husk whilst taking Mounjaro, it is advisable to consult your GP, diabetes specialist nurse, or prescribing clinician

Calculate your syringe units for 0.25 mg using the conversion chart above (or use the semaglutide dosage calculator )

Most people stopped because of stomach problems